NCT06746753View on ClinicalTrials.gov

Dysfunctional Renin-Angiotensin System in Septic Shock

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

January 31, 2026

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2030

Conditions
Septic Shock
Interventions
DRUG

Angiotensin II

randomized to receive Angiotensin II continuous infusion for up to 48 hours

DRUG

Norepinephrine

randomized to receive Norepinephrine continuous infusion for up to 48 hours

Trial Locations (1)

27157

Atrium Health Wake Forest Baptist, Winston-Salem

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Wake Forest University Health Sciences

OTHER